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Abstract
Aims: To evaluate the associations of age at menarche and the leg length-to-sitting-height ratio, markers of adolescent
growth, with risk of diabetes in later life.
Materials and Methods: Information from 69,385 women and 55,311 men, aged 40–74 years from the Shanghai Women’s
Health Study and Shanghai Men’s Health Study, were included in the current analyses. Diabetes status was ascertained
through biennial in person follow-up. Cox models, with age as the time scale, were used.
Results: There were 2369 cases of diabetes (1831 women; 538 men) during an average of 7.3 and 3.6 years of follow-up of
the women and men, respectively. In females, menarche age was inversely associated with diabetes risk after adjustment for
birth cohort, education, and income (HR=0.95, 0.92–0.98). In both genders, leg length-to-sitting-height ratio was inversely
related to diabetes (HR=0.88, 0.80–0.97 for men; HR=0.91, 0.86–0.96 for women) after adjustment for birth cohort,
education, and income. Further adjustment for adult BMI at study enrollment completely eliminated the associations of age
at menarche (HR=0.99, 0.96–1.02) and the leg length-to-sitting-height ratio (HR=1.00, 0.91–1.10 for men; HR=1.01, 0.96–
1.07 for women) with diabetes risk.
Conclusions: Our study suggests that markers of an early age at peak height velocity, i.e. early menarche age and low leg-
length-to-sitting height ratio, may be associated with diabetes risk later in life and this association is likely to be mediated
through obesity.
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Introduction
Factors associated with early life nutrition have been suggested
to be associated with future risk of diabetes and other chronic
diseases. Low birth weight, early adiposity rebound [1], early
menarche [2], and BMI in late adolescence have all been found to
be associated with the future risk of impaired glucose tolerance, the
metabolic syndrome, and/or diabetes. Shorter adult stature has
been found to be associated with impaired glucose tolerance [3]
and gestational diabetes [4]. Few studies have evaluated markers
of early life nutrition with diabetes risk in population-based
settings. Two previous studies have linked longer leg length and a
higher leg-to-trunk length ratio with a lower prevalence of type 2
diabetes [4,5] and an association between an earlier age at
menarche and risk of diabetes later in life [6,7] has been recently
reported.
Diabetes is an increasing problem in developing countries,
which have seen increases in height [8], reduction in menarche
age, and improvements in economic status [9]. The leg-length-to-
sitting-height ratio is considered a marker of prepubertal
nutritional status [10] and a marker of the age at pubertal onset
[10], with a longer-leg-length to sitting height ratio associated with
a later age at pubertal onset [10], age at menarche [11], and peak
height velocity [12]. We evaluated the relationship of markers of
adolescent growth with risk of diabetes in later life using data from
the Shanghai Women’s Health Study and the Shanghai Men’s
Health Study, two large population-based cohort studies of
approximately 130,000 middle-aged and elderly women and men.
Methods
The Shanghai Women’s Health Study and the Shanghai Men’s
Health Study are population-based prospective studies of Chinese
women aged 40 to 70 years and men aged 40 to 74 years living in
urban communities of Shanghai. The two cohort studies were
designed to investigate the association of diet and lifestyle factors
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March 20, 2012with chronic diseases. The study design, methods, and baseline
questionnaires have been previously described [13,14]. Briefly,
trained personnel recruited 74,942 women between March 1997
and May 2000 and 61,499 men between March 2002 and June
2006 and conducted in-person interviews. The overall response
rates were 92% for women and 75% for men. The study protocols
were approved by the institutional review boards of all institutes
involved in the studies, and written informed consent was obtained
from all participants prior to interview. During the interview, data
on dietary habits, physical activity, reproductive history, educa-
tional attainment, income, occupation, and physician diagnosis of
specific chronic diseases, including diabetes, were collected using
structured questionnaires. The cohorts are followed-up by biennial
in-person survey and record linkage with the Shanghai vital
statistic registry. During follow-up, each participant was asked
whether he/she had been diagnosed by a physician to have
diabetes since study enrollment. Participants who reported a
physician diagnosis of diabetes were further asked if they received
positive results on blood glucose tests for having a blood glucose
concentration $11.1 mmol/L, or on two separate occasions a
fasting glucose concentration of $7 mmol/L. Diabetes cases
included in this study met at least one of the following criteria: a
fasting glucose concentration of $7 mmol/L on two separate
occasions, $11.1 mmol/L glucose concentration on an oral
glucose tolerance test and/or use of a hypoglycemic agent. All
other self-reported cases of diabetes were excluded from analyses.
Anthropometric data was collected during the baseline
interview. Standing and sitting height, and weight at baseline
were measured by the trained interviewers according to a
standardized protocol. Body mass index (BMI) was calculated as
the weight in kilograms divided by the square of the height in
meters. Information on age at menarche was collected on the
baseline questionnaire.
We categorized birth cohorts into eight categories by approx-
imately three-year intervals. These categories were chosen to
coincide with major political and societal changes that have
resulted in a major impact on food and nutrient availability to the
general Chinese population in China. For example, the 1946–
1949 birth cohort was born during the Chinese civil war. The
major famine in Chinese recent history occurred between 1959
and 1961 [15]. This is the period when the cohort of 1946–1949
reached their adolescence. The famine may have temporarily
delayed menarche age among pre-puberty girls and had an impact
on leg/standing height ratio, as has been observed in Europe [16].
There were 7356 (3492 women; 3864 men) participants who
reported having diabetes at baseline and another 1,805 tested
positive for glucose in their urine at baseline, and these
participants were excluded from analyses. Because the association
between height components with age at puberty onset has been
shown to vary by sex [10], analyses were conducted sex-
specifically. General linear modeling analysis was used to
determine the age-adjusted differences in continuous data. The
chi-square test was used to determine differences in categorical
data. Cox proportional hazards analysis with age as the time scale
was used to determine the multivariable adjusted association of
age at menarche and the leg-length-to-sitting-height ratio with risk
of diabetes. Covariates adjusted in the analysis include birth cohort
(modeled categorically), educational attainment level, and house-
hold income. Additional analyses with further adjustment for BMI
at study enrollment were carried out to examine whether BMI was
the mediator for early life exposure associated with subsequent risk
of diabetes in later life. Finally, further adjustment BMI at age 20,
physical activity during adolescence (participation in a team sport),
and smoking prior to age at menarche (for analyses with age at
menarche) or prior to age 20 was made. As the correlation
between BMI at age 20 and baseline BMI was modest (r=0.23,
p,0.0001) both BMI at age 20 and BMI at baseline were included
in the same model (using the residuals of BMI at study baseline
regressed on BMI at age 20 resulted in identical estimates). All
analyses were conducted using SAS 9.1.3 (Cary, N.C.).
Results
Participants were followed for a mean of 7.3 (61.3) years
(women) and 3.6 (1.3) years (men). Characteristics of study
participants by diabetes status are presented in Table 1.
Participants who developed diabetes (1831 women and 538
men) were older, less educated, and in women, from a lower
income household. Birth weight did not differ between cases and
noncases (data not shown). Baseline BMI (at study enrollment) was
significantly higher in those who developed diabetes compared to
those who did not.
Univariate analysis suggested that a later age at menarche was
related to a reduced risk of diabetes. Compared to the lowest
quintile, higher quintiles of age at menarche were associated with a
reduced risk of diabetes (Table 2). After adjustment for birth
cohort, education, household income (markers of childhood and
current socioeconomic status) (Model 2), a statistically significant
inverse association was observed which disappeared after further
adjustment for baseline BMI (Model 3). Additional adjustment for
BMI at age 20 and participation in a team sport during
adolescence (Model 4) had no additional effect beyond that
observed in Model 3, although a lower BMI at age 20 and a higher
baseline BMI were associated with a higher risk of diabetes (data
not shown).
Table 3 presents the relative risk of diabetes by the leg-length-
to-sitting-height ratio. In both men and women, the leg-length-to-
sitting-height ratio was inversely associated with risk of diabetes.
This inverse association persisted in multivariate analysis with
adjustment for birth cohort, education and income. When
evaluated as a continuous variable, each 1 standard deviation
increase in the leg length-to-sitting-height ratio was associated with
a 9% reduction in risk of diabetes in women and a 12% risk
reduction in men (Model 2). After further controlling for baseline
BMI, the leg-length-to-sitting-height ratio was no longer associated
with risk of diabetes in either women or men (Model 3). Further
adjustment for smoking prior to age 20, BMI at age 20, baseline
BMI, participation in team sports during adolescence, and
smoking prior to age 20 (Model 4) had no additional effect
beyond that of adjustment for baseline BMI in Model 3.
The risk of diabetes associated with total height and the
individual height components are presented in Tables 4 and 5 for
women and men, respectively. In women, there was a positive
association with total height that emerged after controlling for
study baseline BMI, but that disappeared upon further adjustment
for BMI at age 20, smoking prior to age 20, and participation in
team sports during adolescence. There was also a positive
association with sitting height in women that disappeared after
adjustment for baseline BMI (models 3 and 4), but an inverse
association with leg length that disappeared after multivariable
adjustment in women. In men, there was no association observed
for total height or sitting height, but an inverse association was
observed for leg length that disappeared upon multivariable
analysis.
Discussion
Few studies have evaluated markers of growth during
adolescence and diabetes risk after age 40. In this report we have
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i.e. a greater leg-length-to-sitting-height ratio, and in women, a
later age at menarche, are associated with a reduced risk of
diabetes in later life. These associations were completely
attenuated after adjustment for recent BMI, suggesting obesity
mediates some of this risk. Other mechanisms by which a later age
at pubertal growth acceleration and a later age at menarche may
be related to the risk of diabetes in adulthood include poor in utero
and early childhood nutrition and hormonal factors involved in
growth and puberty regulation.
The leg-length-to-sitting-height ratio is a marker of timing of
puberty and peak height velocity [17]. Prior to the pubertal growth
spurt, growth is more rapid in the legs, whereas during and after
the pubertal growth spurt, growth is more rapid in the trunk and
head. Thus the leg length to sitting height ratio progressively rises
until around the age of peak height velocity in both males and
females and then begins to decline [18]. An earlier age at peak
height velocity, suggestive of an earlier entry into puberty, and
subsequent fusion of the epiphyseal growth plate, would result in
an earlier cessation of long bone growth, but not truncal growth,
and thus a lower adult leg-length-to-sitting-height ratio. To our
knowledge, only a few studies have evaluated the leg length, or leg
length to sitting height ratio, in association with risk of type 2
diabetes. Shorter adult stature, a shorter leg length, and a shorter
leg-length-to-standing-height ratio have been linked to the
prevalence of type 2 diabetes in the National Health and Nutrition
Examination Survey (NANES) III [4]. Although height was no
longer statistically significant in that population after further
adjustment for potential confounders such as a parental history of
diabetes and socioeconomic status, leg length and the leg-length-
Table 1. Age-adjusted Characteristics of Study Participants by Incident Diabetes Status: the Shanghai Women’s and Shanghai
Men’s Health Study, mean (SD) or % (n).
Women Men
Cases (n=1831) Non-cases (n=67,554) Cases (n=538) Non-cases (n=54,773)
Age at interview (years) 56.0 (8.9) 51.5 (8.9)
* 57.0 (9.6) 54.4 (9.6)
*
Age at diagnosis (years) 60.1 (2.0) N/A 58.5 (0.91) N/A
Education
Less than middle school 35.1 (642) 19.2 (12,992)
* 8.1 (43) 6.2 (3,320)
*
Middle school or high school 54.3 (994) 66.7 (45,043) 69.5 (371) 70.1 (37,865)
College and above 10.7 (195) 14.1 (9,507) 22.5 (120) 23.7 (12,809)
Income**
Low 32.9 (603) 26.8 (18,106)
* 52.7 (283) 55.0 (30,053)
Middle 38.7 (709) 38.8 (26,207) 37.4 (201) 35.2 (19,243)
High 28.4 (519) 34.4 (23,226) 9.9 (53) 9.8 (5,360)
BMI at age 20 (kg/m
2) 19.4 (2.7) 19.6 (2.6)
* 19.7 (2.1) 19.5 (2.1)
Baseline BMI (kg/m
2) 26.4 (3.3) 23.8 (3.3)* 26.0 (3.1) 23.6 (3.1)
*
Started smoking before age 20 years** 0.27 (5) 0.23 (154) 15.4 (83) 18.6 (10,212)
Participated in a team sport in adolescence** 11.4 (209) 12.5 (8,454) 22.1 (119) 22.4 (12,261)
N/A=not applicable
*=p,0?05
**Low income=1: less 1000 yuans, Middle income=2: 1000–1999 yuans, High income=3: .=2000 yuans.
doi:10.1371/journal.pone.0030625.t001
Table 2. Risk of Diabetes in Middle Age by Age at Menarche, HR (95% CI).
Model 1 Model 2 Model 3 Model 4
Quintiles of Age at menarche
Quintile 1 1.00 1.00 1.00 1.00
Quintile 2 0.87 (0.75–1.02) 0.84 (0.72–0.99) 0.91 (0.78–1.07) 90 (0.77–1.05)
Quintile 3 0.93 (0.80–1.08) 0.86 (0.74–1.01) 0.96 (0.83–1.12) 0.95 (0.81–1.11)
Quintile 4 0.92 (0.79–1.08) 0.83 (0.70–0.97) 0.98 (0.83–1.16) 0.95 (0.81–1.12)
Quintile 5 0.87 (0.74–1.02) 0.74 (0.63–0.88) 0.91 (0.77–1.08) 0.88 (0.75–1.05)
Continuous* 0.98 (0.95–1.01) 0.95 (0?92–0?98) 0.99 (0.96–1.02) 0.98 (0.95–1.01)
Descriptive statistics for age at menarche by quintiles of age at menarche are: Quintile 1: mean=12 years, range=8–13 years, std=0.56 years;
Quintile 2: mean=14years, range=14–14 years, std=0 years; Quintile 3: mean=15 years, range=15–15 years, std=0 years; Quintile 4: mean=16
years, range=16–16 years, std=0 years; Quintile 5: mean=17 years, range=17–26 years, std=0. 89 years.
*Expressed as per standard deviation change.
Model 1: univariate analyses. Model 2 controlled for birth cohort, education and income. Model 3 controlled for birth cohort, education, income, and BMI at baseline.
Model 4 controlled for birth cohort, education, income, BMI at age 20, BMI at baseline, and participation in team sports during adolescence.
doi:10.1371/journal.pone.0030625.t002
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prevalence of diabetes [4]. Upon further adjustment for body fat,
the leg-length-to-standing-height ratio remained associated with
the prevalence of type 2 diabetes.
The onset of puberty requires reaching a critical level of either
height or body fat. Poor in utero nutrition leading to insulin
resistance [19,20] in childhood and thus increased insulin levels
may result in increased anabolism in bone, muscle, and adipose
tissue and an earlier age at reaching these critical levels of height
and/or body fat. In females, hyperinsulinemia is associated with
both accelerated onset and progression through puberty [21].
Most previous studies, while finding an association between age
at menarche and glucose tolerance [2,22,23], have failed to find an
association between age at menarche and risk of type 2 diabetes
[2,24], possibly, as suggested by Lakshman et al, due to low
statistical power [7]. In a study of 13,308 female participants of the
Norfolk cohort of the European Prospective Investigation into
Cancer and Nutrition (EPIC-Norfolk), Lakshman et al found that
an earlier age at menarche was associated with the risk of type 2
diabetes [7]. However, this association was accounted for by body
mass index in adulthood. In our study as well, BMI partially
mediated the association between age at menarche and diabetes
risk.
The effect of both age at menarche and final attained height on
risk of diabetes may be mediated through estrogen. Estrogen is
responsible for the onset of menstruation and the acceleration of
growth during puberty. However, estrogen has a biphasic effect on
linear growth [25]. At relatively low levels it causes an increase in
growth velocity, while at high levels it is responsible for the closure
of the epiphyseal plates, resulting in the cessation of long bone
growth and thus the end of linear growth in adolescence. A later
age at menarche has been repeatedly shown to be related to
increased adult height [26]. In our population as well, a later age
at menarche was associated with an increased final attained height
(data not depicted). Endogenous levels of estradiol are positively
associated with insulin and glucose and with type 2 diabetes [27],
although exogenous estrogen replacement has been shown to
increase insulin sensitivity and decrease the risk of type 2 diabetes.
The latter has been suggested to be dependent on the route of
estrogen delivery [28,29]. Transdermal estradiol therapy was
shown to increase plasma glucose levels in women [30], while oral
estrogen therapy decreases glucose levels [29].
Estrogen also inhibits production of insulin-like growth factor-1
(IGF-1) [31,32] and low levels of IGF-1 are associated with an
increased risk type 2 diabetes [33]. IGF-1 is a hormone with
structural and functional homology to insulin and helps regulate
postnatal somatic and bone growth [34]. Serum levels of IGF-1
follow the pattern of somatic growth, increasing in puberty, and
declining down toward prepubertal levels after adolescence [35].
IGF-1 also promotes pancreatic growth, increases in beta cell
mass, and protects against islet cell apoptosis [36]. Although
postnatal pancreatic growth is greatest in the first year of life, the
pancreas does continue to grow during childhood and adoles-
cence. If pancreatic growth follows a pattern similar to the rise of
IGF-1 with somatic growth, it is possible that earlier cessation of
linear growth, as suggested by an earlier age at peak height
velocity, would result in a reduced final pancreatic size and beta
cell mass as it does with a reduced final attained height. In
Table 3. Risk of Diabetes in Middle-aged and Older Chinese Women and Men by the Leg–Length-to-Sitting-Height Ratio, HR (95%
CI).
Model 1 Model 2 Model 3 Model 4
Women
Quintiles of Leg-Length-to-Sitting-Height Ratio
Quintile 1 1.00 1.00 1.00 1.00
Quintile 2 0.98 (0.84–1.15) 0.99 (0.84–1.15) 1.13 (0.97–1.32) 1.12 (0.96–1.31)
Quintile 3 0.87 (0.74–1.02) 0.87 (0.74–1.03) 1.07 (0.91–1.26) 1.06 (0.90–1.25)
Quintile 4 0.94 (0.80–1.10) 0.94 (0.80–1.10) 1.21 (1.03–1.42) 1.19 (1.01–1.39)
Quintile 5 0.77 (0.65–0.91) 0.77 (0.66–0.91) 1.06 (0.90–1.26) 1.03 (0.87–1.22)
Continuous
* 0.90 (0.85–0.95) 0.91 (0.86–0.96) 1.01 (0.96–1.07) 1.00 (0.95–1.06)
Men
Quintiles of Leg-Length-to-Sitting-Height Ratio
Quintile 1 1.00 1.00 1.00 1.00
Quintile 2 0.65 (0.49–0.88) 0.65 (0.48–0.88) 0.76 (0.56–1.03) 0.76 (0.56–1.03)
Quintile 3 0.66 (0.49–0.89) 0.68 (0.51–0.92) 0.85 (0.63–1.15) 0.85 (0.63–1.15)
Quintile 4 0.80 (0.61–1.07) 0.84 (0.63–1.11) 1.10 (0.82–1.47) 1.09 (0.82–1.46)
Quintile 5 0.66 (0.49–0.89) 0.66 (0.50–0.89) 0.93 (0.69–1.25) 0.92 (0.68–1.24)
Continuous* 0.88 (0.79–0.97) 0.88 (0.80–0.97) 1.00 (0.91–1.10) 0.99 (0.90–1.09)
Descriptive statistics for the leg-length-to-sitting-height ratio by quintiles of the leg-length-to-sitting-height in women are as follows: Quintile 1:
mean=0.80, range=0.43–0.82, std=0.02; Quintile 2: mean=0.84, range=0.82–0.85, std=0.008; Quintile 3: mean=0.86, range=0.85–0.88,
std=0.007; Quintile 4: mean=0.89, range=0.88–0.91, std=0.009; Quintile 5: mean=0.95, range=0.91–2.02, std=0.05.
Descriptive statistics for the leg-length-to-sitting-height ratio by quintiles of the leg-length-to-sitting-height in men are as follows: Quintile 1:
mean=0.82, range=0.43–0.84, std=0.02; Quintile 2: mean=0.85, range=0.84–0.87, std=0.007; Quintile 3: mean=0.88, range=0.87–0.89,
std=0.006; Quintile 4: mean=0.90, range=0.89–0.91, std=0.008; Quintile 5: mean=0.94, range=0.91–1.46, std=0.03.
*Expressed as per standard deviation change.
Model 1: univariate analyses. Model 2 controlled for birth cohort, education, and income. Model 3 controlled for birth cohort, education, income, and BMI at baseline.
Model 4 controlled for birth cohort, education, income, smoking before age 20, BMI at age 20, BMI at baseline, and participation in team sports during adolescence.
doi:10.1371/journal.pone.0030625.t003
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Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Continuous*
Total Height
Model 1 1.00 1.09 (0.93–1.27) 0.98 (0.84–1.15) 1.09 (0.93–1.28) 1.02 (0.86–1.21) 1.00 (0.94–1.05)
Model 2 1.00 1.12 (0.96–1.30) 1.03 (0.88–1.21) 1.16 (0.98–1.36) 1.11 (0.93–1.32) 1.03 (0.97–1.09)
Model 3 1.00 1.19 (1.02–1.39) 1.14 (0.97–1.33) 1.26 (1.07–1.48) 1.25 (1.05–1.49) 1.07 (1.02–1.13)
Model 4 1.00 1.17 (1.00–1.36) 1.11 (0.94–1.30) 1.21 (1.03–1.43) 1.17 (0.98–1.39) 1.05 (0.99–1.11)
Leg Length
Model 1 1.00 0.96 (0.82–1.11) 0.92 (0.79–1.07) 0.94 (0.80–1.10) 0.88 (0.74–1.03) 0.94 (0.89–0.97)
Model 2 1.00 0.97 (0.84–1.14) 0.94 (0.81–1.10) 0.98 (0.83–1.15) 0.93 (0.79–1.10) 0.96 (0.91–1.01)
Model 3 1.00 1.09 (0.93–1.27) 1.11 (0.95–1.30) 1.20 (1.02–1.41) 1.20 (1.01–1.42) 1.05 (1.00–1.11)
Model 4 1.00 1.06 (0.91–1.24) 1.09 (0.93–1.27) 1.16 (0.99–1.36) 1.12 (0.94–1.33) 1.03 (0.98–1.09)
Sitting Height
Model 1 1.00 1.13 (0.98–1.32) 1.05 (0.89–1.25) 1.12 (0.95–1.31) 1.27 (1.08–1.50) 1.08 (1.02–1.14)
Model 2 1.00 1.17 (1.01–1.36) 1.10 (0.92–1.31) 1.17 (1.00–1.38) 1.36 (1.15–1.61) 1.11 (1.05–1.17)
Model 3 1.00 1.13 (0.97–1.31) 1.01 (0.85–1.20) 1.10 (0.93–1.29) 1.19 (1.00–1.40) 1.05 (1.00–1.11)
Model 4 1.00 1.11 (0.96–1.29) 0.98 (0.82–1.16) 1.06 (0.90–1.25) 1.14 (0.96–1.35) 1.04 (0.98–1.10)
Descriptive statistics for height components by quintiles in women: Height (m): Quintile 1: mean=1.50, range=1.19–1.54, std=0.03; Quintile 2: mean=1.55,
range=1.54–1.57, std=0.008; Quintile 3: mean=1.58, range=1.57–1.60, std=0.008; Quintile 4: mean=1.61, range=1.60–1.63, std=0.009; Quintile 5: mean=1.66,
range=1.63–1.86, std=0.02. Leg Length (cm): Quintile 1: mean=68.3, range=0.40–0.70, std=1.86; Quintile 2: mean=71.4, range=70–72.3, std=0.59; Quintile 3:
mean=73.4, range=72.3–74.0, std=0.54; Quintile 4: mean=75.4, range=74.05–76.5, std=0.60; Quintile 5: mean=78.9, range=76.5–105.0, std=2.18. Sitting height
(cm): Quintile 1: mean=80.3, range=52.0–82.0, std=2.13; Quintile 2: mean=83.5, range=82.1–84.0, std=0.53; Quintile 3: mean=85.0, range=84.1–85.9, std=0.30;
Quintile 4: mean=86.5, range=86.0–87.0, std=0.47; Quintile 5: mean=89.2, range=87.1–105.0, std=1.48.
*Expressed as per standard deviation change. Model 1: univariate analyses. Model 2 controlled for birth cohort, education, and income. Model 3 controlled for birth
cohort, education, income, and BMI at baseline. Model 4 controlled for birth cohort, education, income, smoking before age 20, BMI at age 20, BMI at baseline, and
participation in team sports during adolescence.
doi:10.1371/journal.pone.0030625.t004
Table 5. Risk of Diabetes in Middle-aged and Older Chinese Men by Height Components, HR (95% CI).
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Continuous*
Height
Model 1 1.00 0.88 (0.65–1.19) 0.93 (0.70–1.24) 0.84 (0.61–1.16) 0.92 (0.68–1.25) 0.97 (0.87–1.07)
Model 2 1.00 0.87 (0.64–1.19) 0.96 (0.71–1.28) 0.88 (0.64–1.21) 0.97 (0.72–1.32) 0.99 (0.90–1.10)
Model 3 1.00 0.93 (0.68–1.26) 1.00 (0.75–1.34) 0.94 (0.69–1.29) 1.02 (0.75–1.39) 1.01 (0.91–1.12)
Model 4 1.00 0.92 (0.68–1.25) 0.97 (0.74–1.32) 0.92 (0.67–1.27) 0.99 (0.73–1.36) 1.00 (0.90–1.11)
Leg Length
Model 1 1.00 1.02 (0.77–1.36) 1.07 (0.80–1.43) 0.87 (0.64–1.18) 0.74 (0.53–1.02) 0.90 (0.82–0.99)
Model 2 1.00 1.01 (0.76–1.36) 1.10 (0.82–1.47) 0.90 (0.66–1.23) 0.77 (0.56–1.06) 0.92 (0.83–1.01)
Model 3 1.00 1.14 (0.85–1.53) 1.29 (0.96–1.73) 1.10 (0.81–1.50) 0.97 (0.70–1.34) 1.00 (0.91–1.10)
Model 4 1.00 1.13 (0.84–1.52) 1.28 (0.95–1.71) 1.08 (0.79–1.48) 0.94 (0.68–1.31) 1.00 (0.90–1.10)
Sitting Height
Model 1 1.00 0.77 (0.55–1.07) 1.05 (0.78–1.41) 0.98 (0.71–1.36) 1.19 (0.87–1.64) 1.07 (0.97–1.19)
Model 2 1.00 0.78 (0.56–1.09) 1.10 (0.81–1.48) 1.01 (0.73–1.41) 1.25 (0.91–1.72) 1.10 (0.99–1.22)
Model 3 1.00 0.74 (0.53–1.04) 0.98 (0.73–1.32) 0.88 (0.63–1.22) 1.00 (0.72–1.38) 1.02 (0.92–1.12)
Model 4 1.00 0.74 (0.53–1.03) 0.97 (0.72–1.31) 0.87 (0.62–1.21) 0.98 (0.71–1.35) 1.01 (0.91–1.12)
Descriptive statistics for height components by quintiles in men: Height (m): Quintile 1: mean=1.62, range=1.15–1.65, std=0.03; Quintile 2: mean=1.67,
range=1.65–1.69, std=0.009; Quintile 3: mean=1.70, range=1.69–1.72, std=0.008; Quintile 4: mean=1.73, range=1.72–1.75, std=0.008; Quintile 5: mean=1.78,
range=1.75–1.96, std=0.03. Leg Length (cm): Quintile 1: mean=74.1, range=37–76, std=2.02; Quintile 2: mean=77.5, range=76.1–78.9, std=0.61; Quintile 3:
mean=79.5, range=79–80, std=0.47; Quintile 4: mean=81.4, range=80–82.5, std=0.61; Quintile 5: mean=84.9, range=82.5–101, std=2.06. Sitting height (cm):
Quintile 1: mean=85.6, range=56.087.9, std=1.84; Quintile 2: mean=88.6, range=88.0–90.0, std=0.53; Quintile 3: mean=90.5, range=90.0–91.5, std=0.53; Quintile 4:
mean=92.4, range=91.6–93.1, std=0.47; Quintile 5: mean=95.2, range=93.1–108.0, std=1.51.
*Expressed as per standard deviation change. Model 1: univariate analyses. Model 2 controlled for birth cohort, education, and income. Model 3 controlled for birth
cohort, education, income, and BMI at baseline. Model 4 controlled for birth cohort, education, income, smoking before age 20, BMI at age 20, BMI at baseline, and
participation in team sports during adolescence.
doi:10.1371/journal.pone.0030625.t005
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mass, decreased glucose tolerance is observed [37].
As higher prepubertal BMI is associated with an earlier entry
into puberty and an earlier age at menarche, and being overweight
in childhood and adolescence tends to track into adulthood, it is
possible that our markers of somatic growth are just predicting
adult BMI. Although we did not have data on BMI before age 20
and thus could not adjust for prepubertal BMI, overweight or
obesity during adolescence appeared to be very low in our study
population as the mean BMI at age 20 was 19.6 and 19.5 kg/m
2
in both women and men, respectively; only 2% of the women 1%
of the men had a BMI above 25 kg/m
2 at age 20. Adjustment for
BMI at age 20 had no additional affect beyond that of BMI in
older adulthood, i.e. BMI at baseline (enrollment). Adjustment for
baseline BMI accounted for the association of age at menarche
and the leg-length-to-sitting height ratio with diabetes incidence in
middle-age and beyond.
Differences in height and height components are determined by
genetic influences in addition to early life nutritional exposure
[38], and thus the generally weaker to null associations between
leg length and total height with diabetes in our study are not
unexpected. By using the leg-length-to-sitting-height ratio in this
racially homogenous population, we were able to minimize the
genetic influence on height. We do not have a good explanation
for the positive association between sitting height and diabetes
incidence in women; however, a positive association between
sitting height and insulin resistance has been observed by others
[38,39]. It has been shown that in Chinese children leg length
growth occurs more rapidly prior to puberty, while truncal growth
occurs more rapidly during puberty [18]. The epiphyseal plates of
the trunk are the last to close and thus truncal bones are the last to
stop growing [40]; nevertheless total final attained height is more
largely determined by long bone, particularly leg, growth. Data
from the Guangzhou Biobank Cohort Study showed that an
earlier age at puberty was associated with shorter legs, a taller
sitting height, and a shorter leg-length-to-sitting-height ratio in
women, but was significantly associated only with a taller sitting
height in men [10]. They also showed that the impact of puberty
on leg length was greater in females than in males [10]. A caveat
needs to be put forth in drawing in conclusions about sex
differences in the relationship with puberty onset with diabetes risk
based on the results of this study, as the small sex difference in our
results may be due to the shorter follow-up time and smaller
number of incident diabetes cases in males than in females.
Strengths of our study include the large sample size, the high
response rates, measured standing and sitting height and BMI, and
a population-based study design. We also controlled for smoking
prior to age 20 as a large percentage of our males were smoking
during adolescence and smoking during adolescence has been
shown to reduce linear growth, particularly in boys [41]. A
potential limitation of our study was that age of menarche was
assessed by recall approximately forty years later. However, it has
been shown that actual age at menarche was strongly correlated
with age at menarche recalled thirty years later by 407 participants
in the Newton Girls Study (r=0.79) [42] with a mean difference of
0.08 years. Another study of 50 year-old women showed a
moderately high correlation (r=0.67). Any influence on our results
due to error in recall of age at menarche is likely to be
nondifferential which would result in underestimation of the
association under study. We did not have data on BMI during
early childhood or prior to menarche and thus our data cannot
determine whether it was early childhood over-nutrition, nutri-
tional deprivation, or early pubarche unrelated to nutritional
status that was driving the results observed between a lower age at
menarche or a shorter leg-length to sitting height ratio and a
higher risk of diabetes later in life. Another limitation was that we
did not have measured data on growth during adolescence or the
leg-length-to-sitting-height ratio in young adulthood, nor did we
have data on IGF-1, estrogen, or pancreatic size, limiting our
discussion of these mechanisms to speculation. Finally, the much
smaller number of cases in men, mainly due to the shorter follow-
up time, limited our ability to evaluate the potential differences
that may exist between men in women in the association of height
components with diabetes incidence. In conclusion, we found that
markers suggestive of an early age at onset of puberty and peak
somatic growth were related to an increased diabetes risk in late
adulthood among both men and women. As in utero and early
childhood nutrition are known to affect somatic growth, our study
suggests that care should be given to prenatal and postnatal/early
childhood nutrition for prevention of diabetes in adulthood.
Finally, our data provide further evidence that weight manage-
ment in later adulthood may be protective against diabetes,
particularly in those who demonstrated an early age at menarche
and linear growth maturation.
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